COMMUNIQUÉS West-GlobeNewswire

NANOBIOTIX signs a 40 M€ non-dilutive financing agreement with the European Investment Bank

26/07/2018 - 18:32

NANOBIOTIX SIGNS A 40 M€ NON-DILUTIVE FINANCING AGREEMENT WITH THE EUROPEAN INVESTMENT BANK Acceleration of company's priorities in head & neck clinical development and market preparation Non-dilutive funding to [...]

NANOBIOTIX signe un accord de financement non-dilutif de 40M€ avec la Banque Européenne d'Investissement

26/07/2018 - 18:32

NANOBIOTIX SIGNE UN ACCORD DE FINANCEMENT NON-DILUTIF DE 40M€ AVEC LA BANQUE EUROPEENNE D'INVESTISSEMENT Accélération des priorités de la Société : développement clinique de l'indication des cancers tête et cou et [...]

HEXO Makes Strategic Investment in Premier Western Canadian Retail Cannabis Operation, Fire & Flower

26/07/2018 - 18:27

GATINEAU, Quebec, July 26, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) is pleased to announce that it has made a strategic $10 million investment into the independent [...]

HEXO fait un investissement stratégique dans Fire & Flower, principal détaillant de cannabis dans l’Ouest canadien

26/07/2018 - 18:27

GATINEAU, Québec, 26 juill. 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX:HEXO) annonce qu’elle a investi 10 millions de dollars dans Fire & Flower Inc. (« Fire & Flower [...]

UPDATE: REVA Enters Peripheral Artery Disease Space With First-Ever CE Mark of a Bioresorbable Scaffold for Below the Knee Therapy

26/07/2018 - 18:24

SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced that its MOTIV™ [...]

Adamas to Announce Second Quarter 2018 Financial Results and Host Conference Call on August 2, 2018

26/07/2018 - 18:05

EMERYVILLE, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the company will report second quarter 2018 financial results on Thursday, August 2, 2018, after [...]

Ziopharm Oncology Board Responds to Recent Stock Price Decline

26/07/2018 - 18:05

- Executing on clinical and business development with plans to add new Board members and expand management team - Annual meeting of stockholders is Sept. 18 BOSTON, July 26, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , [...]

Sharecare acquires Window Channel Network, closes investment from Wells Fargo Strategic Capital

26/07/2018 - 18:00

Digital health company’s twelfth acquisition expands content capabilities in digital mindfulness, relaxation and meditation $20 million investment from Wells Fargo Strategic Capital brings Sharecare’s total funding to $ [...]

GUERBET : Revenue at June 30 2018

26/07/2018 - 17:48

€415.7M at constant exchange rates: +2.1% Villepinte, 26 July 2018 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is reporting revenue of €389.6M for the first [...]

GUERBET : Chiffre d'affaires au 30 juin 2018

26/07/2018 - 17:48

415,7 M€ à taux de change constant : +2,1% sur le 1 er semestre Villepinte, le 26 juillet 2018 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, publie un [...]

ADMA Biologics Reports Successful Close-Out of its April 2018 FDA Compliance Inspection

26/07/2018 - 16:50

FDA Establishment Inspection Report (“EIR”) Received RAMSEY, N.J. and BOCA RATON, Fla., July 26, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA” or the “Company”), a vertically integrated commercial [...]

Savara Announces Pricing of Public Offering of Common Stock

26/07/2018 - 15:15

AUSTIN, Texas, July 26, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (Nasdaq:SVRA), an orphan lung disease company, today announced the pricing of an underwritten public offering of 4,250,000 shares of its common stock at a [...]

Software Veteran James Lim Joins Syapse as Senior Vice President of Product Development

26/07/2018 - 15:00

Lim will lead development of the Syapse software platform to support precision medicine initiatives at a growing number of health systems and life sciences partners SAN FRANCISCO, July 26, 2018 (GLOBE NEWSWIRE) -- [...]

Village Farms Increases Licensed Cannabis Footprint, On Track for More Value-Driving Milestones This Year -- CFN Media

26/07/2018 - 15:00

SEATTLE, July 26, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]

Amarin Announces Approval for Vascepa® in United Arab Emirates

26/07/2018 - 14:48

Approval is Second Middle East Country to Approve Vascepa Sale Following Lebanon Earlier This Year BEDMINSTER, N.J. and DUBLIN, Ireland, July 26, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a [...]

UPDATE -- Tetra Bio-Pharma Confirms Meetings With FDA

26/07/2018 - 14:43

Type B & C Meetings Move TBP Closer to Market Approval ORLEANS, Ontario, July 26, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., (“ Tetra ” or the “ Company ”) a leader in cannabinoid-based drug discovery and [...]

Interpace Diagnostics Announces CIGNA’s Expansion of Coverage to Now Include ThyraMIR®

26/07/2018 - 14:37

National Plan Coverage for miRNA-based Classifier PARSIPPANY, N.J., July 26, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) (“Interpace” or “the Company”), a fully integrated commercial and [...]

Surgery Partners, Inc. Announces Second Quarter 2018 Earnings Release Date and Conference Call Details

26/07/2018 - 14:31

NASHVILLE, Tenn., July 26, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that the Company will release its [...]

Minerva Neurosciences to Report Second Quarter 2018 Financial Results and Business Updates on August 2, 2018

26/07/2018 - 14:30

Management to host conference call WALTHAM, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat [...]